Skin Fluorescent Imaging (SFI) System in Patients With Nevi (NCT04368247) | Clinical Trial Compass
CompletedNot Applicable
Skin Fluorescent Imaging (SFI) System in Patients With Nevi
United States300 participantsStarted 2020-08-10
Plain-language summary
The Sponsor has developed the Skin Fluorescent Imaging (SFI) system, an in vivo imaging modality, for the purpose of providing physicians with insight into the biological changes occurring during tissue remodeling in a nevus.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
In order to be eligible to participate in this study a subject must meet all of the following criteria:
* Provide a signed and dated informed consent form
* Age ≥ 18 years old
* Subjects must present with suspicious atypical nevi scheduled for a biopsy\*
* Nevi with at least 1 cm of skin surrounding the mole
* Nevi must be accessible to the SFI imaging device
* Excisional or a tangential excision with a dept of 1 to 2 mm biopsy will be performed for the mole tested within 21 days of testing.
* Nevi with clinically atypical features
Only 1 mole per eligible subject will be SFI tested in this study. \*NOTE: a subset of patients (\~10%) with benign nevi (by clinical observation) who wish to have nevi removed for cosmetic reasons will be enrolled as negative controls.
Exclusion Criteria:
An individual who meets any of the following criteria will be excluded from participation in this study:
* Subjects who are younger than 18 years old
* Lesions that are consistent with
\- Features of Keratosis and keratin plugs
* Basal Cell Carcinoma
* Squamous Cell Carcinoma
* Challenging anatomical location (e.g., body cervices)
* Subjects with nevi that fit the inclusion criteria but are:
* Less than 1 cm from the eyes
* On the palms of the hands or soles of the feet
* Associated with scar tissue
* Mucosal lesions
* Ulcerated lesions / breached skin
* Lesions with some clinical certainty of being melanomas (large, dark, etc.)
* Any nevi with in…